Evidence map›Paper›PMID 42332804›Full record

Observational studyCritical care (London, England)2026

SvO₂ response to red blood cell transfusion in cardiovascular surgical icu patients: a retrospective observational study.

Kentaro Okamoto, Kimito Minami, Chase Donaldson, Jean Deschamps, Marcelo Gama de Abreu, Shigeki Fujitani, Takaki Naito, Tatsutoshi Shimatani, Muneyuki Takeuchi

Abstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kentaro OkamotoDepartment of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan. beetle5522@gmail.com.
Kimito MinamiDepartment of Critical Care Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Chase DonaldsonDepartment of Intensive Care and Resuscitation, Cleveland Clinic Main Campus Hospital, Cleveland, OH, USA.
Jean DeschampsDepartment of Intensive Care and Resuscitation, Cleveland Clinic Main Campus Hospital, Cleveland, OH, USA.
Marcelo Gama de AbreuDepartment of Intensive Care and Resuscitation, Cleveland Clinic Main Campus Hospital, Cleveland, OH, USA.
Shigeki FujitaniDepartment of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Takaki NaitoDepartment of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.
Tatsutoshi ShimataniDepartment of Critical Care Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Muneyuki TakeuchiDepartment of Critical Care Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRed blood cell (RBC) transfusion decisions after cardiovascular surgery require integration of hemoglobin (Hb), hemodynamics, bleeding status, and oxygen supply-demand balance. Mixed venous oxygen saturation (SvO₂) reflects the global relationship between oxygen delivery and oxygen consumption, but an increase in SvO₂ does not necessarily indicate improved tissue oxygenation or clinical benefit. We evaluated acute SvO₂ changes after RBC transfusion in cardiovascular surgical ICU patients.

methodsWe conducted a single-center retrospective cohort study of adult cardiovascular surgical ICU patients who received one RBC-equivalent transfusion with pre-transfusion Hb ≥ 7.5 g/dL and paired pre- and post-transfusion SvO₂ measurements. The primary outcome was an individual-level SvO₂ response, defined a priori as ΔSvO₂ ≥5% points from baseline to approximately 60 min after transfusion initiation. Multivariable regression was used to evaluate predictors selected a priori based on physiologic relevance to oxygen delivery and consumption. Receiver operating characteristic analysis was used to evaluate the discriminative ability of pre-transfusion SvO₂.

results1,352 unique patients met the final inclusion criteria. Mean Hb increased from 9.82 ± 0.92 to 10.24 ± 0.98 g/dL, corresponding to a paired mean difference of 0.42 g/dL (95% CI, 0.38 to 0.46; P < 0.001). Mean SvO₂ changed minimally at the cohort level, from 73.79 ± 9.91% to 73.86 ± 9.37%, corresponding to a paired mean difference of 0.08% points (95% CI, -0.28 to 0.43; P = 0.671). Lower pre-transfusion SvO₂ was associated with a higher probability of an individual-level SvO₂ response. In multivariable logistic regression, pre-transfusion SvO₂ was associated with SvO₂ response (adjusted odds ratio, 0.89 per 1% increase; 95% confidence interval, 0.86-0.91; P < 0.001). Pre-transfusion SvO₂ showed moderate discrimination for SvO₂ response, with an area under the curve of 0.778 (95% confidence interval, 0.740-0.816). The Youden-derived cutoff was 69%, which should be interpreted as an exploratory predictor of acute SvO₂ rise rather than a transfusion trigger.

conclusionsLower pre-transfusion SvO₂ was associated with acute individual-level SvO₂ increase after transfusion, but mean SvO₂ change was minimal. The association did not establish tissue oxygenation or clinical benefit and does not support using SvO₂, including the 69% cutoff, as a transfusion indication or trigger.

Indexed as

Cardiovascular Surgical ProceduresErythrocyte TransfusionOxygenOxygen ConsumptionOxygen SaturationAgedCohort StudiesFemaleHemoglobinsHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesROC CurveHemoglobinsOxygenCardiac surgeryCardiovascular intensive careMixed venous oxygen saturationOxygen deliveryPhysiologic responseRed blood cell transfusionSvO₂

Identifiers

PMID42332804
PMCPMC13317303

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.